Form 8-K - Current report:
SEC Accession No. 0000950170-24-068196
Filing Date
2024-06-04
Accepted
2024-06-03 19:17:59
Documents
11
Period of Report
2024-05-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mura-20240530.htm   iXBRL 8-K 80194
  Complete submission text file 0000950170-24-068196.txt   199432

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mura-20240530.xsd EX-101.SCH 28203
14 EXTRACTED XBRL INSTANCE DOCUMENT mura-20240530_htm.xml XML 4682
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41837 | Film No.: 241015614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)